More frequent hemodialysis: What do we know? Where do we stand?

Contributions to Nephrology

Volumn 171, Issue , 2011, Pages 10-16

  Raimann, Jochen G ^a,b   Thijssen, Stephan ^a,b   Ramos, Rosio ^a   Levin, Nathan W ^a  

^a RENAL RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; MORTALITY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 84925954667     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000327331     Document Type: Article

References (22)

1. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St. Peter W, Guo H, Li Q, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers PW, Agodoa L: Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010;55(suppl 1):S1- 420, A6- 7.
2. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347: 2010-2019. (Pubitemid 35461657)
3. Locatelli F, Martin- Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R: Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009;20:645-654.
4. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-534. (Pubitemid 15248043)
5. Charra B, Calemard M, Laurent G: Importance of treatment time and blood pressure control in achieving long- term survival on dialysis. Am J Nephrol 1996;16:35-44. (Pubitemid 126506938)
6. Saran R, Bragg- Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69:1222-1228.
7. Vanholder R, Smet RD, Glorieux G, Dhondt A: Survival of hemodialysis patients and uremic toxin removal. Artif Organs 2003;27:218-223. (Pubitemid 36423475)
8. DePalma JR, Pecker EA, Maxwell MH: A new automatic coil dialyzer system for 'daily' dialysis. Hemodial Int 2004;8:19-23. (Pubitemid 41029668)
9. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M: Daily dialysis: long- term clinical metabolic results. Kidney Int Suppl 1988;24:S137-S140. (Pubitemid 18078157)
10. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, Uldall R: Nocturnal hemodialysis: three- year experience. J Am Soc Nephrol 1998;9:859-868.
11. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S: Long- term study of high- comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003;42:1020-1035. (Pubitemid 37322919)
12. Lockridge RS Jr, Spencer M, Craft V, Pipkin M, Campbell D, McPhatter L, Albert J, Anderson H, Jennings F, Barger T: Nightly home hemodialysis: five and one- half years of experience in Lynchburg, Virginia. Hemodial Int 2004;8:61-69. (Pubitemid 41029674)
13. Lindsay RM: The London, Ontario, Daily/Nocturnal Hemodialysis Study. Semin Dial 2004;17:85-91. (Pubitemid 38560977)
14. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005;16: 2778-2788.
15. Altman DG: Randomisation. BMJ 1991;302:1481-1482.
16. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott- Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007;298:1291-1299. (Pubitemid 47443343)
17. Schorr M, Manns BJ, Culleton B, Walsh M, Klarenbach S, Tonelli M, Sauve L, Chin R, Barnieh L, Hemmelgarn BR: The Effect of Nocturnal and Conventional Hemodialysis on Markers of Nutritional Status: Results From a Randomized Trial. J Ren Nutr, E- pub ahead of print.
18. Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, Kliger AS, on behalf of the FHN Trial Group: Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials. Am J Kidney Dis 2010;57: 90-100.
19. Ware JE Jr, Sherbourne CD: The MOS 36- item short- form health survey (SF- 36). I. Conceptual framework and item selection. Med Care 1992;30: 473-483.
20. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS, on behalf of the FHN Trial Group: Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int 2007;71:349-359. (Pubitemid 46227095)
21. Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM, on behalf of the FHN Trial Group: Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis 2011;57:101-112.
22. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS, on behalf of the FHN Trial Group: Incenter hemodialysis six times per week versus three times per week. N Engl J Med 2010;363:2287-2300.